Named on one round in the feed.
Since 2026-03-31
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$100M
across 1 round
CO-INVESTORS
6
named beside it
Named on one round in the feed.
Since 2026-03-31
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Ambrosia Biosciences Small molecule-based therapies for obesity and metabolic disorders, aimed at healthcare providers and patients. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-03-31 | [ PART ] |
No sector on record.